Rufu Chen[Author] - Search Results

Year	Number of Results
2004	1
2005	3
2006	2
2007	7
2008	1
2009	2
2010	4
2011	1
2012	5
2013	3
2014	3
2015	17
2016	9
2017	11
2018	7
2019	3
2020	9
2021	12
2022	9
2023	18
2024	4

1

Inflammatory cytokine-regulated tRNA-derived fragment tRF-21 suppresses pancreatic ductal adenocarcinoma progression.

Pan L, Huang X, Liu ZX, Ye Y, Li R, Zhang J, Wu G, Bai R, Zhuang L, Wei L, Li M, Zheng Y, Su J, Deng J, Deng S, Zeng L, Zhang S, Wu C, Che X, Wang C, Chen R, Lin D, Zheng J. Pan L, et al. Among authors: chen r. J Clin Invest. 2021 Nov 15;131(22):e148130. doi: 10.1172/JCI148130. J Clin Invest. 2021. PMID: 34779408 Free PMC article.

2

KRAS mutant-driven SUMOylation controls extracellular vesicle transmission to trigger lymphangiogenesis in pancreatic cancer.

Luo Y, Li Z, Kong Y, He W, Zheng H, An M, Lin Y, Zhang D, Yang J, Zhao Y, Chen C, Chen R. Luo Y, et al. Among authors: chen r. J Clin Invest. 2022 Jul 15;132(14):e157644. doi: 10.1172/JCI157644. J Clin Invest. 2022. PMID: 35579947 Free PMC article.

3

Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer.

Chen C, Luo Y, He W, Zhao Y, Kong Y, Liu H, Zhong G, Li Y, Li J, Huang J, Chen R, Lin T. Chen C, et al. Among authors: chen r. J Clin Invest. 2020 Jan 2;130(1):404-421. doi: 10.1172/JCI130892. J Clin Invest. 2020. PMID: 31593555 Free PMC article.

4

Single-cell RNA sequencing reveals spatiotemporal heterogeneity and malignant progression in pancreatic neuroendocrine tumor.

Zhou Y, Liu S, Liu C, Yang J, Lin Q, Zheng S, Chen C, Zhou Q, Chen R. Zhou Y, et al. Among authors: chen r. Int J Biol Sci. 2021 Aug 28;17(14):3760-3775. doi: 10.7150/ijbs.61717. eCollection 2021. Int J Biol Sci. 2021. PMID: 34671197 Free PMC article.

5

circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis.

Hu C, Xia R, Zhang X, Li T, Ye Y, Li G, He R, Li Z, Lin Q, Zheng S, Chen R. Hu C, et al. Among authors: chen r. Mol Cancer. 2022 Jan 19;21(1):24. doi: 10.1186/s12943-022-01501-3. Mol Cancer. 2022. PMID: 35045883 Free PMC article.

6

Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours: a multicentre, open-label, randomised controlled trial.

Wang M, Li D, Chen R, Huang X, Li J, Liu Y, Liu J, Cheng W, Chen X, Zhao W, Li J, Tan Z, Huang H, Li D, Zhu F, Qin T, Ma J, Yu G, Zhou B, Zheng S, Tang Y, Han W, Meng L, Ke J, Feng F, Chen B, Yin X, Chen W, Ma H, Xu J, Liu Y, Lin R, Dong Y, Yu Y, Liu J, Zhang H, Qin R; Minimally Invasive Treatment Group in the Pancreatic Disease Branch of China's International Exchange and Promotion Association for Medicine and Healthcare (MITG-P-CPAM). Wang M, et al. Among authors: chen r. Lancet Gastroenterol Hepatol. 2021 Jun;6(6):438-447. doi: 10.1016/S2468-1253(21)00054-6. Epub 2021 Apr 27. Lancet Gastroenterol Hepatol. 2021. PMID: 33915091 Clinical Trial.

7

Mutant KRAS Mediates circARFGEF2 Biogenesis to Promote Lymphatic Metastasis of Pancreatic Ductal Adenocarcinoma.

Kong Y, Luo Y, Zheng S, Yang J, Zhang D, Zhao Y, Zheng H, An M, Lin Y, Ai L, Diao X, Lin Q, Chen C, Chen R. Kong Y, et al. Among authors: chen r. Cancer Res. 2023 Sep 15;83(18):3077-3094. doi: 10.1158/0008-5472.CAN-22-3997. Cancer Res. 2023. PMID: 37363990 Free PMC article.

8

Super-enhancer RNA m⁶A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarcinoma.

Li R, Zhao H, Huang X, Zhang J, Bai R, Zhuang L, Wen S, Wu S, Zhou Q, Li M, Zeng L, Zhang S, Deng S, Su J, Zuo Z, Chen R, Lin D, Zheng J. Li R, et al. Among authors: chen r. Nat Genet. 2023 Dec;55(12):2224-2234. doi: 10.1038/s41588-023-01568-8. Epub 2023 Nov 13. Nat Genet. 2023. PMID: 37957340

9

Long non-coding RNA cox-2 prevents immune evasion and metastasis of hepatocellular carcinoma by altering M1/M2 macrophage polarization.

Ye Y, Xu Y, Lai Y, He W, Li Y, Wang R, Luo X, Chen R, Chen T. Ye Y, et al. Among authors: chen r. J Cell Biochem. 2018 Mar;119(3):2951-2963. doi: 10.1002/jcb.26509. Epub 2017 Dec 12. J Cell Biochem. 2018. PMID: 29131381

10

LINC00842 inactivates transcription co-regulator PGC-1α to promote pancreatic cancer malignancy through metabolic remodelling.

Huang X, Pan L, Zuo Z, Li M, Zeng L, Li R, Ye Y, Zhang J, Wu G, Bai R, Zhuang L, Wei L, Zheng Y, Su J, Deng J, Deng S, Zhang S, Zhu S, Che X, Wang C, Wu C, Chen R, Lin D, Zheng J. Huang X, et al. Among authors: chen r. Nat Commun. 2021 Jun 22;12(1):3830. doi: 10.1038/s41467-021-23904-4. Nat Commun. 2021. PMID: 34158490 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

121 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Results by year